NCT02891512View on ClinicalTrials.gov

"Very Low Frequency Magnetic Fields Versus the Supplement Xinepa in the Treatment of the Carpal Tunnel Syndrome"

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

January 31, 2016

Conditions
Carpal Tunnel Syndrome
Interventions
OTHER

ELF

Very low frequency magnetic fields (ELF) at intensity of 100 mT and a frequency of 1-80 Hz. Protocol (antiedema-antinflammatory): 12 sessions, 3 times a week for 4 consecutive weeks, each session lasted 30 minutes.

OTHER

Xinepa®

2 tablets of Xinepa daily (morning and evening) for 1 month.

OTHER

Placebo Xinepa®

2 tablets of Xinepa placebo daily (morning and evening) for 1 month.

Trial Locations (1)

00165

Umberto I Hospital, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02891512 - "Very Low Frequency Magnetic Fields Versus the Supplement Xinepa in the Treatment of the Carpal Tunnel Syndrome" | Biotech Hunter | Biotech Hunter